Organogenesis Holdings Inc. Class A Common Stock (ORGO) Stock
NASDAQ · ORGO
1.42
Fundamentals
Market cap
$182.72M
Price / Earnings ratio
-1.7x
Price / Sales ratio
0.4x
Price / Book ratio
1.2x
Return on assets
-0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Organogenesis Holdings Inc. Class A Common Stock
No description available.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees854
CEOMr. Gary S. Gillheeney Sr.
IPO DateJan 5, 2017
HeadquartersCanton, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Gary S. Gillheeney Sr. | President, CEO, Chair of the Board | 1955 |
| Mr. David C. Francisco | Chief Financial Officer | 1966 |
| Mr. Patrick Bilbo | Chief Operating Officer | 1962 |
| Ms. Lori H. Freedman B.A., Esq., J.D. | Chief Administrative & Legal Officer | 1967 |
| Mr. Brian Grow | Chief Commercial Officer | 1976 |
| Mr. Patrick McGuire | Chief Accounting Officer | 1986 |
| Mr. Robert Cavorsi | Chief Business Officer | 1979 |
| Mr. William R. Kolb CPA | Secretary | — |
Fundamentals
Valuation
Market cap$182.72M
Price-to-sales ratio0.38
Price-to-book value1.18
Price-earnings ratio-1.70
Return on Equity-7.00%
Return on Sales0.01%
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.82
Income Statement
Average volume678,992
EBITDA$36.65M
1 year high (52w)$7.08
1 year low (52w)$1.36
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



